Popular Articles

Risk For Obesity Increased By Short Sleep Duration And Race
According to a research abstract presented on June 8, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, race significantly influences the risk of obesity conferred by short sleep duration, with blacks having a greater risk than whites.

Life Spine(R) Announces FDA Clearance Of FS3(TM) Minimally Invasive Spinal System
Life Spine announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the FS3 Minimally Invasive Spinal System.
News of the day
Global Fund Faces $3B Funding Shortfall
The Global Fund to Fight AIDS, Tuberculosis and Malaria is facing a budget shortfall of about $3 billion, Marcela Rojo, a Global Fund spokesperson, said on Friday, Reuters reports. Rojo said the Global Fund needs $170 million to pay for the programs it committed to supporting last year, and the organization will need between $2.5 billion and $3 billion to maintain and finance programs planned for 2010. "The Global Fund will need a substantially higher amount than the one pledged at the last replenishment in Berlin in 2007 ($10 billion)," Rojo said, adding, "The decisions that are made in the next 18 months will be critical for sustaining the gains achieved in global health so far and further scaling up programmes."
Sexual Health

Deworming Drug Could Help Reduce Spread Of HIV In Africa, Study Finds

Providing girls in rural Africa with a deworming drug could help reduce the spread of HIV, according to a study recently published in PLoS Neglected Tropical Diseases, the New York Times reports. The drug, called praziquantel, costs about 32 cents per pediatric dose and prevents schistosomiasis, a worm disease that starts as a urinary tract infection. If untreated, schistosomiasis can lead to female genital sores that can facilitate HIV infection. Because the drug can kill the worms but cannot cure genital sores, girls should be protected before they reach sexual maturity, according to the Times. "For this relatively small investment, the reproductive health of young women would be improved," the authors from the Sabin Vaccine Institute, Imperial College London and Oslo University wrote, adding that "there is a reasonable chance that HIV/AIDS transmission can be reduced." There are about 207 million schistosomiasis cases worldwide, 90% of which occur in Africa, where humans are exposed usually through snail-infested water. According to a pilot program conducted in Burkina Faso, all 70 million cases among young children in Africa could be treated for $22 million, and repeating universal treatment every two years for 10 years would cost $112 million (McNeil, New York Times, 5/26). The study is available online. Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):